About Leveragen
Leveragen is a company based in Cambridge (United States) founded in 2017 by Weisheng V Chen.. Leveragen offers products and services including Genetic Engineering Platform and Antibody Discovery Platform. Leveragen operates in a competitive market with competitors including Novogene Corporation, Rejuvenate Bio, Source BioScience, Strateos and Beikang Medical, among others.
- Headquarter Cambridge, United States
- Founders Weisheng V Chen
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Leveragen, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Leveragen
Leveragen offers a comprehensive portfolio of products and services, including Genetic Engineering Platform and Antibody Discovery Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for genome editing and biotherapeutics development using CRISPR
System for identifying and engineering antibodies via phage display
Unlock access to complete
Leadership Team
3 people
Principal Team
2 people
Software Development Team
1 people
Principle Team
1 people
Unlock access to complete
Funding Insights of Leveragen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Leveragen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Leveragen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Leveragen Comparisons
Competitors of Leveragen
Leveragen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novogene Corporation, Rejuvenate Bio, Source BioScience, Strateos and Beikang Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
|
| domain | founded_year | HQ Location |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| domain | founded_year | HQ Location |
Multiple genomic services are provided for analysis and diagnostics.
|
|
| domain | founded_year | HQ Location |
Provider of cloud based platform provides data driven information for biotech research
|
|
| domain | founded_year | HQ Location |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| domain | founded_year | HQ Location |
Next-generation sequencing and genomics services are provided globally.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Leveragen
When was Leveragen founded?
Leveragen was founded in 2017.
Where is Leveragen located?
Leveragen is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
What does Leveragen do?
Leveragen was founded in 2017 and is based in Cambridge, United States. Operations focus on the biotechnology sector, where customized genetic modeling services are delivered through CRISPR-facilitated gene targeting in embryonic stem cells. Mutations are screened in these cells prior to knockout mouse development, enabling large fragment knockins and complex genetic modifications for research applications.
Who are the top competitors of Leveragen?
Leveragen's top competitors include Novogene Corporation, Source BioScience and Genewiz.
What products or services does Leveragen offer?
Leveragen offers Genetic Engineering Platform and Antibody Discovery Platform.